The best indicator for ResMed (RMD)
We backtested 382 indicators across daily, weekly and hourly charts on real ResMed (RMD) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Where ResMed (RMD) stands
Computed from our own daily OHLCV history, not quoted from a third party. Moving averages use closing prices; "52-week" is the last 252 trading sessions.
Detrended Price Osc.
On the weekly chart, this is the strongest risk-adjusted edge we found for ResMed (RMD) over ~31.1 years — trailing buy-and-hold by 4.7% CAGR.
ResMed (RMD) on the weekly chart
The timeframe our backtest found best for this asset. The chart is live market data; the results above are hypothetical and historical.
Chart by TradingView. Loading it contacts tradingview.com, which may set its own cookies — see our privacy policy.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for ResMed (RMD) — trailing buy-and-hold by 10.1% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Detrended Price Osc. ✓ | Weekly | 16.0% | 0.72 | -40.3% | 56.1% | 180 | -4.7% |
| 2 | DeMarker ✓ | Daily | 14.3% | 0.69 | -34.6% | 71.8% | 110 | -6.5% |
| 3 | Markov Regime ✓ | Daily | 18.6% | 0.64 | -61.6% | 63.9% | 119 | -2.3% |
| 4 | MA Envelope ✓ | Daily | 13.3% | 0.62 | -63.6% | 67.7% | 217 | -7.5% |
| 5 | QQE ✓ | Weekly | 17.0% | 0.62 | -62.1% | 57.8% | 90 | -3.7% |
| 6 | SMA 20/50 Cross ✓ | Weekly | 17.1% | 0.66 | -54.5% | 78.6% | 14 | -3.6% |
| 7 | QQE ✓ | Daily | 17.3% | 0.61 | -59.3% | 45.8% | 454 | -3.5% |
| 8 | ROC (60) ✓ | Weekly | 15.8% | 0.61 | -54.5% | 67.7% | 31 | -4.9% |
| 9 | CCI (100) ✓ | Weekly | 15.6% | 0.61 | -55.2% | 47.6% | 21 | -5.2% |
| 10 | Lorentzian Classification ✓ | Weekly | 15.1% | 0.61 | -59.5% | 55.6% | 250 | -5.6% |
| 11 | Volume Flow Indicator ✓ | Daily | 15.4% | 0.6 | -57.3% | 47.8% | 67 | -5.4% |
| 12 | Murrey Math Lines ✓ | Daily | 12.2% | 0.6 | -52.8% | 83.1% | 77 | -8.6% |
| 13 | Williams %R ✓ | Daily | 12.0% | 0.59 | -66.3% | 66.0% | 194 | -8.9% |
| 14 | Williams %R ✓ | Weekly | 11.1% | 0.59 | -40.3% | 76.9% | 39 | -9.7% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
What it would take to beat buy & hold on ResMed (RMD)
11 of 673 tested setups beat buy-and-hold on ResMed (RMD) outright. Another 92 could get there with leverage they would survive — but 251 would be liquidated by their own drawdown before they caught it.
| Indicator | Beats B&H unlevered | Leverage needed | Leverage survived |
|---|---|---|---|
| Demand Index | 1 | 1.13× | 3.44× |
| MA Envelope | 1 | 1.39× | 3.88× |
| Williams %R | 1 | 1.42× | 4.03× |
| Detrended Price Osc. | 1 | none needed | 2.59× |
| Volume Flow Indicator | 1 | none needed | 2.83× |
| Pivot Points (Standard) | 1 | none needed | 2.8× |
Out-of-sample, costs included. A setup is only listed if the leverage it needs is less than the leverage its own worst drawdown survives — when it isn't, no amount of leverage gets there. Volatility drag isn't modelled, so these are the optimistic case. Every indicator, ranked this way
For ResMed (RMD), Detrended Price Osc. on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get alerted when ResMed’s signal flips
We track ResMed daily. Its backtested best indicator, Detrended Price Osc. (Weekly), is flat right now — we'll email you the moment that changes. Free, no spam, unsubscribe any time.